Table 1 Percentage of people in Norway born before 1945 who purchased antihypertensive drugs during 2005–2010
From: Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study
| Â | Total cohort | By sex | By birth cohort | ||||
|---|---|---|---|---|---|---|---|
|  | n = 906,422 | Women | Men | 1935-1944 | 1925–1934 | 1915–1924 | <1915 |
n = 506,568 | n = 399, 854 | n = 397,761 | n = 294,952 | n = 183,967 | n = 29,742 | ||
Thiazide | 6.2 | 7.1 | 5.2 | 2.8 | 2.3 | 1.0 | 0.1 |
Loop diuretic | 17.9 | 19.4 | 15.9 | 5.0 | 7.1 | 5.3 | 0.5 |
Beta blocker | 29.8 | 28.6 | 31.3 | 12.1 | 11.6 | 5.8 | 0.3 |
Calcium channel blocker | 21.6 | 21.5 | 21.6 | 8.9 | 8.4 | 4.1 | 0.2 |
ACE inhibitor | 14.0 | 12.4 | 16.0 | 5.4 | 5.4 | 2.9 | 0.3 |
ACE inhibitor/Thiazide | 3.8 | 2.1 | 1.7 | 1.7 | 1.4 | 0.7 | <0.1 |
Angiotensin II receptor blocker | 16.5 | 16.8 | 16.1 | 7.9 | 6.0 | 2.4 | 0.1 |
Angiotensin II receptor blocker/Thiazide | 14.0 | 8.1 | 5.9 | 7.0 | 5.1 | 1.8 | 0.1 |